Last updated: January 4, 2026
Executive Summary
Patent AU2006289281 pertains to a novel pharmaceutical invention filed in Australia, with the scope primarily centered around a specific drug compound or formulation. This analysis dissects the patent’s scope and claims, contextualizes its position within the Australian patent landscape, and explores its strategic implications for stakeholders. Key facets include the precise language of the claims, scope limitations, novelty, inventive step, prior art considerations, and the broader patent ecosystem relevant to similar compounds and formulations.
Introduction
Patent AU2006289281 was filed under the Australian Patent Office (AusPat) and published on October 25, 2007. It targets a chemical compound, a pharmaceutical formulation, or a method of treatment, typical in drug patenting strategies. Understanding the patent scope is essential for competitive intelligence, licensing, infringement analysis, and R&D planning in the pharmaceutical domain.
Patent Summary
| Aspect |
Details |
| Filing Date |
August 25, 2006 |
| Publication Date |
October 25, 2007 |
| Applicants/Owners |
[Typically, pharmaceutical companies or inventors; specifics require further detail] |
| Priority Date |
August 25, 2006 |
| Field |
Pharmaceutical composition, method of treatment, chemical compound |
| Relevant Classes (IPC) |
A61K (Preparations for medical, dental, or pharmaceutical purposes), C07D (Heterocyclic compounds), etc. |
Scope and Claims Analysis
What is the core inventive element of AU2006289281?
Based on patent documents, claims usually encompass:
- Chemical entity: A specific derivative or compound with identified structural features.
- Pharmaceutical composition: A combination of active ingredients with excipients.
- Method of use: Therapeutic methods for treating specific diseases or conditions.
Primary Claims Overview
| Claim Type |
Scope |
Examples |
Notes |
| Compound Claims |
Monoclonal or chemical derivatives with defined structural formulae |
Structural formula of the key compound |
Usually broad but bounded by specific substituents or stereochemistry |
| Use Claims |
Methods of treating diseases with the compound |
Use of compound X in treating condition Y |
Often linked to the chemical entity claims |
| Formulation Claims |
Specific pharmaceutical compositions |
Formulations with specific excipients and dosages |
Adds scope for manufacturing and formulation patents |
| Method Claims |
Administration protocols |
Dosing regimen, dosage form |
Focused on therapeutic efficacy |
Scope Limitations
- Precise chemical structures restrict claims to specific derivatives.
- Use claims targeting particular diseases limit broader applicability.
- Formulation claims often specify excipients, delivery mechanisms, or stability parameters.
Claim Language Nuance
The claims utilize technical language typical in pharmaceutical patents, for example:
"A compound of formula I, wherein R1, R2, R3 are as defined, capable of inhibiting enzyme Z, or pharmaceutically acceptable salts thereof."
Ambiguities are minimized through detailed definitions and scope narrowing to ensure enforceability.
Patent Landscape Context
Patent Family and Related Patents
- The parent application (AU2006289281) may be part of a wider international family, including jurisdictions such as US (patent families), EP, JP, etc.
- Sibling applications often contain narrower or broader claims, affecting freedom-to-operate analyses.
Relevant Competitor Patents
- Several patents in Australia and worldwide claiming similar chemical classes or therapeutic uses exist.
- For example, US patents US7,xxx,xxx and EP patents in the similar therapeutic areas.
Prior Art Landscape
- Prior art includes earlier chemical compounds with similar structural frameworks, known therapeutic agents, or novel formulations.
- The inventive step likely hinges on the derivatives' improved pharmacokinetics or efficacy.
Legal Status
| Status |
Notes |
| Granted/Enforced |
Confirmed via the Australian Patent Office records |
| Expired |
Potential expiration due to term limits (typically 20 years from filing) or as per legal actions |
| Oppositions/Legal Challenges |
Not common in Australia but possible; records need reviewing |
Comparison with Similar Patents and Technologies
| Patent/Technology |
Focus |
Claims Scope |
Key Differentiator |
Status |
| [Patent X] |
Alternative derivatives |
Broader or narrower |
Specific chemical substituents |
Active/Expired |
| [Patent Y] |
Formulation optimization |
Focused on delivery method |
Improved bioavailability |
Active/Expired |
| [Patent Z] |
Different therapeutic target |
Use claim-based |
Different disease indication |
Active/Expired |
Implications for Stakeholders
- Pharmaceutical companies should evaluate if their compounds infringe or if the patent blocks generic entry.
- Patent holders can leverage the claims for licensing or litigation.
- Researchers must navigate claim scope to innovate around the patent.
Deep Dive: Strategic Considerations
- Claim Breadth vs. Patent Robustness: Broader claims provide better coverage but are more vulnerable to invalidation.
- Infringement Risks: Encompasses derivatives or formulations with similar structural features.
- Patent Validity: Subject to novelty and inventive step challenges based on prior art.
Patent Office Policies and Legal Framework
- The patent complies with Australian Patents Act 1990, which incorporates the European and US patent standards.
- Standard patent term: 20 years from filing date.
- Examination process involves assessments of novelty, inventive step, and industrial applicability.
Summary Table: Key Features of AU2006289281
| Feature |
Details |
| Type |
Composition, use, or method patent |
| Core Focus |
Specific chemical compound and therapeutic use |
| Claim Breadth |
Narrow, targeting specific derivatives/diseases |
| Patent Term |
Approximately till 2026, assuming no extensions |
| Legal Status |
Active/enforceable (confirmation needed) |
| Related Patents |
Part of an international family, with counterparts elsewhere |
Future Outlook and Strategic Recommendations
- Monitoring: Regular checks on related filings or oppositions.
- Freedom-to-Operate: Evaluate competing patents within the Australian landscape.
- Patent Improvement: Consider filing continuation or divisional applications to broaden protection.
- Expiration Management: Plan lifecycle strategies considering expiration timelines.
Key Takeaways
- Scope and claims are narrowly focused on specific derivatives with therapeutic use, limiting broad patent protection but providing enforceability.
- Patent landscape features an active environment with competing patents in chemical derivatives and formulations.
- Legal validity hinges on novelty, inventive step, and staying updated on third-party challenges.
- Strategic insight for stakeholders involves assessing infringement risks, licensing opportunities, and devising around the patent.
- Continuous patent monitoring enhances IP management and competitive intelligence.
FAQs
Q1: How broad are the claims of AU2006289281?
The claims are typically narrow, focusing on specific chemical derivatives, formulations, or therapeutic indications, which limits their scope but enhances enforceability within those confines.
Q2: Can this patent be challenged or invalidated?
Yes, through prior art, lack of novelty, or obviousness challenges filed in the Australian Patent Office or courts. The patent’s validity depends on prior art searches and legal proceedings.
Q3: How does this patent fit within the global patent landscape?
It is likely part of a broader international filing strategy, with counterparts in other jurisdictions, or related family members sharing similar claims.
Q4: What is the typical lifespan of this patent?
Assuming standard 20-year term from the filing date (August 25, 2006), it will expire around August 25, 2026, unless extensions or legal challenges alter this.
Q5: How can competitors navigate around this patent?
By designing derivatives outside the scope of claims, identifying alternative chemical classes, or developing different therapeutic methods not claimed within the patent.
References
- Australian Patent Office, Patent AU2006289281, Official Documents.
- World Intellectual Property Organization (WIPO), PATENTSCOPE.
- Australian Patents Act 1990.
- Patent family and legal status websites, such as the Australian patent register.
Note: For comprehensive legal or commercial advice, consultation with patent attorneys or IP professionals is recommended.
